Ontogeny of membrane cofactor protein: phenotypic divergence in the fetal heart

Abstract

Human adult cells are protected from complement-induced damage in part by membrane cofactor protein (MCP, CD46). To examine fetal characteristics which might influence autoantibody-mediated diseases acquired in utero, such as heart block in neonatal lupus, the tissue expression of MCP was studied. Using a high ratio of acrylamide:bisacrylamide, immunoblots of tissues from six fetuses (aged 19-24 weeks) probed with rabbit anti-MCP antibodies revealed a band at 60 KD in addition to the known 65 KD and 55 KD isoforms which comprise the codominant allelic system of MCP. Five fetuses expressed the most common MCP polymorphism (predominance of the 65 KD isoform, upper band α-phenotype) in the kidney, spleen, liver and lung. In contrast, all hearts from these five fetuses demonstrated a different pattern in which there was a marked decrease in the intensity of the 65 KD band and accentuation of the lower molecular weight bands. In a sixth fetus, which expressed the second most common polymorphism (equal expression of the 65 KD and 55 KD MCP isoforms, αβ-phenotype), the heart was similar to the other tissues. These studies confirm the expression of MCP in early gestational life. Preferential expression of the MCP β-isoform in the majority of fetal hearts irrespective of the phenotype of other organs, suggests tissue-specific RNA splicing or post-translational modification which may relate to autoantibody-mediated injury in diseases such as neonatal lupus.

Keywords

membrane cofactor protein CD46 heart neonatal lupus

Get full access to this article

View all access options for this article.

References

Nicholson-Weller A. et al. Isolation of a human erythrocyte membrane glycoprotein with decay accelerating activity for C3 convertases of the complement system. J Immunol 1982 ; 129: 184-189.

Ballard LL et al. Biochemical characterization of membrane cofactor protein of the complement system. J Immunol 1988; 141: 3923-3929.

Ojicius DM , Jiang S. , Young Jde.

Restriction factors of homologous complement: a new candidate?

Immunol Today 1990; 11: 47-49.

Seya T. , Turner JR , Atkinson JP Purification and characterization of a membrane protein (gp 45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med 1986; 163: 837-855.

Seya T. et al. Membrane cofactor protein (MCP or gp 45-70): a distinct complement regulatory protein with a wide tissue distribution. Complement 1987; 4: 225 (abstract).

Johnstone RW et al. Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol Immunol 1993; 30: 1231-1241.

Post TW et al. Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline rich exons in cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 1991; 174: 93-102.

Ballard L. et al. A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp 45-70). J Immunol 1987 ; 138: 3850-3855.

Buyon JP , Winchester RJ Complete congenital heart block: a model of passively acquired autoimmunity . Arthritis Rheum 1990; 33: 609-614.

10.

Buyon JP et al. Effective separation of the 52 KDa SSA/Ro polypeptide from the 48 KDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis . J Immunol Meth 1990; 129: 207-210.

11.

Towbin HT , Staehelin J. , Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedures and applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354.

12.

Simpson KL , Houlihan JM , Holmes CH Complement regulatory proteins in early human fetal life: CD59, membrane cofactor protein (MCP) and decay-acclerating factor (DAF) are differentially expressed in the developing liver. Immunology 1993; 80: 183-190.

13.

Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.

14.

Russell SM et al. Tissue-specific and allelic expression of CD46 is controlled at the level of alternative splicing. Eur J Immunol 1992; 22: 1513-1518.

15.

Johnstone RW , Loveland BE , McKenzie Ifc. Identification and quantification of complement regulator CD46 on normal human tissues. Immunology 1993; 79: 341-347.

16.

Lublin DM , Atkinson JP Decay-accelerating factor and membrane cofactor protein. Cur Top Micro Immunol 1989; 153: 124-144.

17.

Loveland BE et al. Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis. Transplant Immunol 1993 ; 1: 101-103.

18.

Lee LA et al. Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro antibody. Am J Med 1987; 83: 793-796.

19.

Taylor PV , Scott JS , Gerlis LM Maternal connective tissue disease and congenital heart block. N Engl J Med 1985; 312: 1328-1329 (letter).

20.

Litsey SE et al. Maternal connective tissue disease and congenital heart block . N Engl J Med 1985; 312: 98-100.

21.

Lockshin MD Neonatal risk to newborns of mothers with systemic lupus erythematosus. Arthritis Rheum 1988; 31: 697-701.

22.

Ramsey-Goldman R. et al. Anti-SSA antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1986; 29: 1269-1273.

23.

Waltuck J. , Buyon JP Autoantibody-associated complete heart block: outcome in mothers and children . Ann Intern Med 1994; 120: 544-551.